As experts around the world continue to develop COVID-19 vaccines and therapeutic compounds, ACM Global Laboratories stands ready to support and optimize these trials. In a commitment to better our communities and do what we can to help support those working to end this pandemic, we are offering discounts and an accelerated review process for COVID-19 studies.
“We at ACM Global Laboratories have the tools, ability and desire to make a difference,” said ACM Global Laboratories Chief Commercial Officer, Thomas Mueller. “COVID-19 is affecting our communities and all who live in them. We are not only committed to using our resources to help defeat the virus, but giving our communities the easiest and fastest means to do so, by prioritizing COVID-19 studies.”
ACM Global Laboratories is a recognized leader in global clinical trials testing services, supporting research studies in more than 65 countries around the globe. With a focus on quality and the ability to provide the skills and bandwidth needed to deliver robust central laboratory services, our scientific experts, project managers and other professionals offer effective strategies and solutions to efficiently execute COVID-19 clinical trials through in-house testing.
ACM is currently supporting solutions to this global pandemic with COVID-19 clinical studies underway and is committed to supporting more in the future.
The COVID-19 trials that we are supporting are benefiting from ACM’s full range of state-of-the-art instruments and testing platforms, which are available to facilitate viral detection and perform assays to evaluate the safety and efficacy of vaccines and therapeutic interventions to treat COVID-19.
“ACM Global Laboratories’ extraordinary teams immediately responded to the need for support for COVID-19 clinical trials as the company has for nearly 25 years, said ACM Global Laboratories President Brian Wright. “When a global crisis happens, effective industry leaders like ACM don’t hesitate to be part of the solution and take actionable steps to mitigate the problem.”
The ACM team is available to conduct immunophenotypic analysis, support routine safety and bioanalytical study needs, coordinate and safely handle SARS CoV-2 PCR and serological antibody testing and provide guidance on vaccine assessment.
ACM Global Laboratories is an affiliate of Rochester Regional Health in Rochester, New York.
ACM Global Laboratories, an affiliate of Rochester Regional Health, is one of the largest global independent central labs in the industry. ACM is certified by the College of American Pathologists (CAP) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology and individual patient care. ACM provides a powerful combination of operational excellence, scientific expertise and unsurpassed global service to customers in more than 65 countries. ACM performs more than 30 million laboratory tests each year—spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit ACMGlobalLab.com or call +1-866-405-0400.
Tel: (732) 501-2624